With 1.12 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.84 million shares. The 52-week range on TRVI shows that it touched its highest point at $5.05 and its lowest point at $2.30 during that stretch. It currently has a 1-year price target of $10.41. Beta for the stock currently stands at 0.92.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TRVI was up-trending over the past week, with a rise of 7.11%, but this was up by 15.60% over a month. Three-month performance surged to 63.18% while six-month performance rose 63.77%. The stock gained 73.85% in the past year, while it has gained 9.71% so far this year. A look at the trailing 12-month EPS for TRVI yields -0.44 with Next year EPS estimates of -0.53. For the next quarter, that number is -0.13. This implies an EPS growth rate of -73.55% for this year and -4.49% for next year. EPS is expected to decline by -27.58% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 27.24%.
Float and Shares Shorts:
At present, 75.45 million TRVI shares are outstanding with a float of 52.84 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for TRVI since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.46579 being high and -$0.49552 being low. For TRVI, this leads to a yearly average estimate of -$0.48561. Based on analyst estimates, the high estimate for the next quarter is -$0.11 and the low estimate is -$0.15. The average estimate for the next quarter is thus -$0.13.
